AIMarketStock 0 FeesIPO Earn
01801 logo

01801 (01801)

Company Profile

Contact Information

Market News

  • Immune Resetting: B-Cell Mediated & Beyond Summit 2026 Oral Presentation: Innovent Biologics Announces Pre-Clinical Results of IBI3055, a Tri-specific T Cell Engager Targeting Autoimmune Diseases2026-04-10T00:00

Financial Highlights

loading